CRISPR Therapeutics AG and Vertex Pharmaceuticals Inc. Receive U.S. Regulatory Approval for Sickle-Cell Disease Treatment
3 Mins read
CRISPR Therapeutics AG (Nasdaq: CRSP) and Vertex Pharmaceuticals Inc. (Nasdaq: VRTX) have announced that they have received U.S. regulatory approval for a…